DSL-Covid-19: Analysis of Suicide Dynamics in Link to the COVID-19 Pandemic

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Recruiting
CT.gov ID
NCT06084143
Collaborator
(none)
2,500
1
12
207.9

Study Details

Study Description

Brief Summary

Covid is a virus that first appeared in China in 2019 and was quickly described as a pandemic virus by its globalized nature. The unprecedented occurrence of the virus has led to several health and restrictive government measures. The Covid-19 pandemic and health measures have been able to contribute to the deterioration of the mental health of citizens as it has already been observed during the former pandemic context (Sars covid in 2003 in China or the Spanish flu).

Among the consequences of a negative impact on mental health, investigators assume that there is an increase in transitions to the completed suicidal act. However, current studies and observations tend to note that there has been no major change in the dynamics of successful suicides during the Covid period.

However, there are biases in the studies conducted: some suicide deaths may have been hidden and not reported as such, due to several factors. For example, the measure of the evolution of suicide attempts that was most often made by the measure of the evolution of the number of hospitalizations for this reason can be a source ofestimate whether people who did this gesture were not hospitalized after a visit to the emergency room or if they gave up attending because of the pandemic. Moreover, suicide deaths are more difficult to report as such when they occur at home than after hospitalization.

It is therefore interesting to study the dynamics of suicide during this health crisis retrospectively based on data from the Strasbourg Institute of Forensic Medicine containing the census of the Alsace region, which was hit hard by the pandemic.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    2500 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Analysis of Suicide Dynamics in Link to the COVID-19 Pandemic
    Actual Study Start Date :
    Jul 21, 2023
    Anticipated Primary Completion Date :
    Jul 21, 2024
    Anticipated Study Completion Date :
    Jul 21, 2024

    Outcome Measures

    Primary Outcome Measures

    1. Suicide rates before and after the Covid-19 pandemic [from January 1, 2018 to December 31, 2021]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Adult patient

    • Died between 01/01/2018 and 12/31/2021

    • Absence of opposition from the patient expressed in writing during his lifetime to the reuse of his personal data for scientific research purposes.

    Exclusion Criteria:
    • Presence of opposition by the patient expressed in writing during his lifetime to the reuse of his personal data for scientific research purposes.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Service de Psychiatrie - CHU de Strasbourg - France Strasbourg France 67091

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT06084143
    Other Study ID Numbers:
    • 9026
    First Posted:
    Oct 16, 2023
    Last Update Posted:
    Oct 16, 2023
    Last Verified:
    Jul 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 16, 2023